Bilibili Inc has a consensus price target of $32.65, established from looking at the 55 latest analyst ratings. The last 3 analyst ratings were released from Benchmark, Barclays, and CLSA on May 24, 2024, May 24, 2024, and May 10, 2024. With an average price target of $15.6 between Benchmark, Barclays, and CLSA, there's an implied 13.21% upside for Bilibili Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
05/24/2024 | Buy Now | 16.11% | Benchmark | Fawne Jiang | $15 → $16 | Maintains | Buy | Get Alert |
05/24/2024 | Buy Now | 1.6% | Barclays | Jiong Shao | $10 → $14 | Upgrade | Underweight → Equal-Weight | Get Alert |
05/10/2024 | Buy Now | 21.92% | CLSA | Elinor Leung | $12.2 → $16.8 | Upgrade | Outperform → Buy | Get Alert |
05/10/2024 | Buy Now | 23.37% | Mizuho | James Lee | $15 → $17 | Maintains | Buy | Get Alert |
03/11/2024 | Buy Now | -9.29% | Citigroup | Brian Gong | $18 → $12.5 | Downgrade | Buy → Neutral | Get Alert |
03/11/2024 | Buy Now | -20.17% | JP Morgan | Daniel Chen | $10 → $11 | Upgrade | Underweight → Neutral | Get Alert |
03/08/2024 | Buy Now | 8.85% | Benchmark | Fawne Jiang | $21 → $15 | Maintains | Buy | Get Alert |
03/08/2024 | Buy Now | 8.85% | Mizuho | James Lee | $16 → $15 | Maintains | Buy | Get Alert |
01/17/2024 | Buy Now | 16.11% | Mizuho | James Lee | $18 → $16 | Maintains | Buy | Get Alert |
12/04/2023 | Buy Now | -4.21% | UBS | Felix Liu | $22 → $13.2 | Downgrade | Buy → Neutral | Get Alert |
11/30/2023 | Buy Now | 52.39% | Benchmark | Fawne Jiang | $35 → $21 | Maintains | Buy | Get Alert |
11/30/2023 | Buy Now | 13.21% | Goldman Sachs | Lincoln Kong | $17.4 → $15.6 | Maintains | Neutral | Get Alert |
11/30/2023 | Buy Now | -27.43% | Barclays | Jiong Shao | $15 → $10 | Downgrade | Equal-Weight → Underweight | Get Alert |
10/12/2023 | Buy Now | 26.27% | Goldman Sachs | Lincoln Kong | $19.6 → $17.4 | Maintains | Neutral | Get Alert |
08/21/2023 | Buy Now | 8.85% | Barclays | Jiong Shao | $16 → $15 | Maintains | Equal-Weight | Get Alert |
08/18/2023 | Buy Now | 59.65% | UBS | Felix Liu | $23 → $22 | Maintains | Buy | Get Alert |
08/18/2023 | Buy Now | 153.99% | Benchmark | Jason English | → $35 | Reiterates | Buy → Buy | Get Alert |
08/18/2023 | Buy Now | 770.83% | Baird | David Koning | $140 → $120 | Maintains | Neutral | Get Alert |
07/27/2023 | Buy Now | -5.66% | JP Morgan | Daniel Chen | → $13 | Downgrade | Overweight → Equal-Weight | Get Alert |
07/25/2023 | Buy Now | 16.11% | HSBC | Charlotte Wei | $17 → $16 | Maintains | Hold | Get Alert |
06/08/2023 | Buy Now | 66.91% | UBS | Felix Liu | $35 → $23 | Maintains | Buy | Get Alert |
06/05/2023 | Buy Now | 153.99% | Benchmark | Jason English | → $35 | Reiterates | Buy → Buy | Get Alert |
06/02/2023 | Buy Now | 153.99% | Benchmark | Jason English | → $35 | Reiterates | Buy → Buy | Get Alert |
06/02/2023 | Buy Now | 81.42% | B of A Securities | Brad Sills | $28 → $25 | Maintains | Buy | Get Alert |
06/02/2023 | Buy Now | 74.17% | Citigroup | Brian Gong | $28 → $24 | Maintains | Buy | Get Alert |
06/02/2023 | Buy Now | 23.37% | HSBC | Charlotte Wei | $22 → $17 | Maintains | Hold | Get Alert |
03/03/2023 | Buy Now | 153.99% | Benchmark | Jason English | → $35 | Reiterates | → Buy | Get Alert |
03/03/2023 | Buy Now | 103.19% | Citigroup | Brian Gong | → $28 | Upgrade | Neutral → Buy | Get Alert |
01/09/2023 | Buy Now | 83.6% | Goldman Sachs | Lincoln Kong | $22.2 → $25.3 | Maintains | Neutral | Get Alert |
11/30/2022 | Buy Now | 61.1% | Goldman Sachs | Lincoln Kong | $25.6 → $22.2 | Maintains | Neutral | Get Alert |
The latest price target for Bilibili (NASDAQ: BILI) was reported by Benchmark on May 24, 2024. The analyst firm set a price target for $16.00 expecting BILI to rise to within 12 months (a possible 16.11% upside). 26 analyst firms have reported ratings in the last year.
The latest analyst rating for Bilibili (NASDAQ: BILI) was provided by Benchmark, and Bilibili maintained their buy rating.
The last upgrade for Bilibili Inc happened on May 24, 2024 when Barclays raised their price target to $14. Barclays previously had an underweight for Bilibili Inc.
The last downgrade for Bilibili Inc happened on March 11, 2024 when Citigroup changed their price target from $18 to $12.5 for Bilibili Inc.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Bilibili, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Bilibili was filed on May 24, 2024 so you should expect the next rating to be made available sometime around May 24, 2025.
While ratings are subjective and will change, the latest Bilibili (BILI) rating was a maintained with a price target of $15.00 to $16.00. The current price Bilibili (BILI) is trading at is $13.78, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.